INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Long Term Provisions History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹0.05 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.03 Cr |
What is the latest Long Term Provisions ratio of INDO US BIOTECH ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹0.05 Cr |
| Mar2024 | ₹0.04 Cr |
| Mar2023 | ₹0.04 Cr |
| Mar2022 | ₹0.04 Cr |
| Mar2021 | ₹0.03 Cr |
How is Long Term Provisions of INDO US BIOTECH Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.05 Cr | 15.91 | |
| Mar2024 | ₹0.04 Cr | 2.33 | |
| Mar2023 | ₹0.04 Cr | 19.44 | |
| Mar2022 | ₹0.04 Cr | 16.13 | |
| Mar2021 | ₹0.03 Cr | - | |
Compare Long Term Provisions of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹252.1 Cr | -3.8% | -5.5% | -56.6% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,123.8 Cr | 0.4% | -2.1% | -19.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,999.1 Cr | 0.1% | -0.2% | 2.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,032.0 Cr | 15% | 15.9% | -23.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,021.7 Cr | -6.7% | -19.1% | -41.5% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹488.7 Cr | -1.3% | 3.6% | 20.5% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -3.8% |
-5.5% |
-56.6% |
| SENSEX | -0.5% |
1.1% |
3.8% |
You may also like the below Video Courses